Author details

Full Name

Yuko Yuki

Affiliation

ORCID

Career Start Year

2008

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37788895	<i>HLA-DPA102:01~B101:01</i> is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cells.	Gut	2024
36877848	HIV post-treatment controllers have distinct immunological and virological features.	Proc Natl Acad Sci U S A	2023
37662332	Insights into the Mechanisms and Structure of Breakage-Fusion-Bridge Cycles in Cervical Cancer using Long-Read Sequencing.	medRxiv	2023
37732256	Understanding the heterogeneity of alloreactive natural killer cell function in kidney transplantation.	bioRxiv	2023
37264229	HLA class I signal peptide polymorphism determines the level of CD94/NKG2-HLA-E-mediated regulation of effector cell responses.	Nat Immunol	2023
37454979	HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44<sup>+</sup> Natural Killer Cells in Ulcerative Colitis.	Gastroenterology	2023
34895481	HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study.	Lancet Oncol	2022
36099881	NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.	Cancer Cell	2022
35858580	Immune correlates of HIV-1 reservoir cell decline in early-treated infants.	Cell Rep	2022
35858344	Genetic variation that determines <i>TAPBP</i> expression levels associates with the course of malaria in an HLA allotype-dependent manner.	Proc Natl Acad Sci U S A	2022
34781719	A Possible Sterilizing Cure of HIV-1 Infection Without Stem Cell Transplantation.	Ann Intern Med	2022
34910552	Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllers.	Sci Transl Med	2021
33852009	HLA Zygosity Increases Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma.	J Infect Dis	2021
33608536	Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013-16 West Africa epidemic.	Nat Commun	2021
33097667	HLA tapasin independence: broader peptide repertoire and HIV control.	Proc Natl Acad Sci U S A	2020
29302013	Elevated <i>HLA-A</i> expression impairs HIV control through inhibition of NKG2A-expressing cells.	Science	2018
25935001	Epigenetic regulation of differential HLA-A allelic expression levels.	Hum Mol Genet	2015
23559252	Influence of HLA-C expression level on HIV control.	Science	2013
24248364	Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease.	Proc Natl Acad Sci U S A	2013
21499264	Differential microRNA regulation of HLA-C expression and its association with HIV control.	Nature	2011
21051598	The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.	Science	2010
19663693	Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa.	Clin Infect Dis	2009
18614631	Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.	J Virol	2008